http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
-
Baxter (BAX) Announces Acquisition of PerClot Polysaccharide Hemostatic System from CryoLife (CRY)
-
Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio
-
Baxter Reports Second-Quarter 2021 Results
-
Baxter Supports Analysis Demonstrating Clinical and Economic Benefits of Effective Intraoperative Blood Management for Surgical Patients
-
Baxter Declares Quarterly Dividend
-
Baxter Launches New 2030 Corporate Responsibility Commitment to Advance Environmental, Social and Governance Priorities
-
Baxter Announces $1.2 Million in New Scholarships and Grant Funding to Support Students Pursuing Health and Sciences at Historically Black Colleges and Universities in the United States
-
Hospital IQ Raises $25 Million to Meet Market Demand for its Software which Optimizes Health System Operations
-
Baxter to Host Second-Quarter 2021 Financial Results Conference Call for Investors
-
Baxter Presents Data at 58th ERA-EDTA Congress Indicating Theranova May Reduce Cardiovascular Events and Hospitalizations
-
Baxter Launches the Sharesource Analytics 1.0 Digital Health Module to Enhance Clinical Management of Home Dialysis Patients
-
Baxter Launches PrisMax 2 System to Advance Critical Care Delivery for Patients and Hospitals
-
Baxter to Present at the UBS Global Healthcare Virtual Conference
-
Baxter Increases Dividend and Declares Quarterly Dividend
-
Baxter Reports First-Quarter 2021 Results
-
Baxter Recognized Globally for Inclusion Efforts
-
Baxter (BAX) Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research
-
Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research
-
Baxter to Present at the BofA Securities 2021 Virtual Health Care Conference
-
Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format
-
Baxter Launches Initiative to Increase Awareness and Education in Black Communities About Kidney Health and Managing Chronic Kidney Disease
-
Baxter to Host First-Quarter 2021 Financial Results Conference Call for Investors
-
Baxter (BAX) Announces U.S. FDA 510(k) Clearance of AK 98 Hemodialysis Machine
-
Baxter Announces U.S. FDA 510(k) Clearance of AK 98 Hemodialysis Machine
-
Baxter to Present at Oppenheimer 31st Annual Healthcare Conference
-
Baxter BioPharma Solutions (BAX) and Moderna (MRNA) Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
-
Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
-
Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director
-
Baxter Declares Quarterly Dividend
-
Baxter Reports Fourth-Quarter and Full-Year 2020 Results
-
Baxter to Present at SVB Leerink 10th Annual Global Healthcare Conference
-
Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
-
Baxter to Host Fourth-Quarter 2020 Financial Results Conference Call for Investors
-
Baxter to Present at the 39th Annual J.P. Morgan Healthcare Conference
-
Baxter and AdventHealth Tampa Announce Cost Savings Achieved Through Intraoperative Hemostasis Management Program
-
Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind.
-
Baxter (BAX) Announces U.S. FDA 510(k) Clearance of Homechoice Claria with Sharesource
-
Baxter Announces U.S. FDA 510(k) Clearance of Homechoice Claria with Sharesource
-
Baxter to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
-
Baxter Declares Quarterly Dividend
-
Baxter Publishes Its First Sustainability Accounting Standards Board (SASB) Index and Celebrates Continued Inclusion in the Dow Jones Sustainability Indices (DJSI)
-
Baxter (BAX) Announces Proposed $650 Million Senior Notes Offering
-
Baxter Announces Proposed $650 Million Senior Notes Offering
-
Baxter Reports Third-Quarter 2020 Results
-
Baxter Supports New Study Showing Blood Purification With Oxiris Filter Set Can Play a Role in the Management of Severely Ill COVID-19 Patients
-
Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
-
Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care
-
Baxter (BAX) Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition
-
Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition

